Rebeiz, Abdallah G <br/><br/>
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).  [electronic resource] 

 -  The American journal of cardiology  Mar 2005 
 - 611-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/j.amjcard.2004.10.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Abciximab<br/>Acetates--therapeutic use<br/>Aged<br/>Antibodies, Monoclonal--therapeutic use<br/>Clinical Trials as Topic<br/>Drug Therapy, Combination<br/>Electrocardiography<br/>Eptifibatide<br/>Female<br/>Humans<br/>Immunoglobulin Fab Fragments--therapeutic use<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Peptides--therapeutic use<br/>Platelet Aggregation Inhibitors--therapeutic use<br/>Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors<br/>Streptokinase--therapeutic use<br/>Survival Analysis<br/>Thrombolytic Therapy--methods<br/>Tissue Plasminogen Activator--therapeutic use<br/>Treatment Outcome<br/>Tyrosine--analogs & derivatives